Search company, investor...
Syneos Health company logo

Syneos Health

syneoshealth.com

Founded Year

1998

Stage

IPO | IPO

Total Raised

$33.93M

Date of IPO

11/7/2014

Market Cap

3.63B

Stock Price

36.17

Revenue

$0000 

About Syneos Health

Syneos Health, fka INC Research, is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to us for a complete range of customized Phase I to IV programs in all therapeutic areas and patient populations. The company's Trusted Process methodology and therapeutic foresight lead customers to better-informed product development decisions, while our solid site relationships are a critical success factor in delivering clinical trial results on time and on budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC.

Headquarters Location

3201 Beecheaf Court Suite 600

Raleigh, North Carolina, 27604,

United States

919-876-9300

Missing: Syneos Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Syneos Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Syneos Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Syneos Health in 3 CB Insights research briefs, most recently on Jul 18, 2022.

Syneos Health Patents

Syneos Health has filed 7 patents.

The 3 most popular patent topics include:

  • Eye surgery
  • Ophthalmology
  • Vision
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/21/2019

10/19/2021

Ophthalmology, Vision, Diseases of the eye and adnexa, Eye surgery, Disorders of choroid and retina

Grant

Application Date

11/21/2019

Grant Date

10/19/2021

Title

Related Topics

Ophthalmology, Vision, Diseases of the eye and adnexa, Eye surgery, Disorders of choroid and retina

Status

Grant

Latest Syneos Health News

Suture Anchors Market Is Predicted to Reach USD 899.4 Million by 2031, Says Allied Market Research

Jan 26, 2023

Impact of Covid-19 on Suture Anchors Market- Discovery and development of suture anchors product slowed down and surgeries of orthopedic patients were postponed during the pandemic impacted the global suture anchors market negatively. However, as the global situation has recovered, the market has now got back on track. The global suture anchors market is analyzed across product type, tying type, material, end user and region. The report takes in an exhaustive analysis of the segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report. By product type, the absorbable segment held the largest share in 2021, garnering around three-fourths of the global suture anchors market revenue, and is projected to maintain its dominance by 2031. The same segment would also showcase the fastest CAGR of 4.9% during the forecast period. By tying type, the knotless segment contributed to nearly three-fourth of the global suture anchors market share in 2021, and is projected to rule the roost by 2031. The same segment would also showcase the fastest CAGR of 4.8% during the forecast period. By material, the bio-composite suture anchor segment accounted for the highest share in 2021, generating nearly half of the global suture anchors market revenue. Other segment, on the other hand, would showcase the fastest CAGR of 5.3% during the forecast period. For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14421 By end user, the ambulatory surgical centers segment accounted for the highest share in 2021, generating nearly half of the global suture anchors market revenue. The hospitals and clinics segment, on the other hand, would showcase the fastest CAGR of 4.7% during the forecast period. By region, North America held the major share in 2021, garnering more than one-third of the global Suture Anchors Market revenue. Asia-Pacific, simultaneously, would showcase the fastest CAGR of 5.8% from 2022 to 2031. The key market players analyzed in the global suture anchors market report include Anika Therapeutics Inc, Arthrex, Inc. CONMED Corporation, Johnson and Johnson, Medtronic plc, Ossio Inc., Paragon 28, Inc, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc. These market players have embraced several strategies including product launch, product approval, and acquisition to highlight their prowess in the industry. The report is helpful in formulating the business performance and developments by the top players. Trending Reports in Healthcare Industry- AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access “We have also published few syndicated market studies in the similar area that might be of your interest. Below is the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.” About Allied Market Research: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences , Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact

Syneos Health Frequently Asked Questions (FAQ)

  • When was Syneos Health founded?

    Syneos Health was founded in 1998.

  • Where is Syneos Health's headquarters?

    Syneos Health's headquarters is located at 3201 Beecheaf Court, Raleigh.

  • What is Syneos Health's latest funding round?

    Syneos Health's latest funding round is IPO.

  • How much did Syneos Health raise?

    Syneos Health raised a total of $33.93M.

  • Who are the investors of Syneos Health?

    Investors of Syneos Health include Avista Capital Partners, InterWest Partners, Adams Street Partners, Crosspoint Venture Partners and SGI Capital.

  • Who are Syneos Health's competitors?

    Competitors of Syneos Health include Vitalief and 1 more.

Compare Syneos Health to Competitors

V
Vitalief

Vitalief is a clinical trials solutions company that supports clients in planning and executing clinical trials. It recruits top talent from across the clinical research industry to support its clients in planning and execution of successful clinical trials with the goal of having a positive impact on people’s lives. The company was founded in 2021 and is based in New Brunswick, New Jersey.

Worldwide Clinical Trials Logo
Worldwide Clinical Trials

Worldwide Clinical Trials is a global, mid-sized CRO that provides top-performing, preclinical, and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986, its full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post-approval, and real-world evidence. Major therapeutic areas of focus include Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases.

Analogic Logo
Analogic

Analogic (Nasdaq:ALOG) provides healthcare and security technology solutions to advance the practice of medicine and save lives. The company is recognized around the world for advanced imaging systems and technology that enable computed tomography, ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. It's CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Analogic's BK Medical and Ultrasonix branded ultrasound systems, used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical end users through it's direct sales force. On June 22nd, 2018, Analogic was taken private by Altaris Capital Partners at a valuation of $1.1B.

Parexel Logo
Parexel

Parexel provides biopharmaceutical services that include a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It offers clinical data management, decentralized clinical trials, medical writing, medical monitoring and consulting, and other services. The company was founded in 1982 and is based in Newton, Massachusetts.

PurpleLab Logo
PurpleLab

PurpleLab is a healthtech company focused on driving decisive actions based on precise insights from real-world data. It develops HealthNexus, a no-code analytics platform that empowers life science, payers, providers, and other healthcare stakeholders to develop real-world evidence (RWE) that therapeutics or clinical strategies are performing and leading to savings in lives and costs. The company semantically harmonizes critical events and relationships between data types at scale, making them analytics-ready. With integrated insights on de-identified patients, providers, and payers, clients receive ongoing objective, quantitative, predictive, and ad hoc real-world evidence to meet their business objectives. These include diagnosis, medications, procedures, measurements, observations, and indications. PurpleLab was founded in 2016 and is based in Wilmington, Delaware.

Koneksa Logo
Koneksa

Koneksa is a healthcare technology company developing digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Its evidence-based biomarker solutions enable efficient clinical trial designs to help therapies reach patients faster. Koneksa specializes in treatment effect detection in clinical research and aims to improve patient outcomes. The company was founded in 2015 and is based in New York, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.